39669377|t|Predictive role of neuron-specific enolase and S100-beta in early neurological deterioration and unfavorable prognosis in patients with ischemic stroke.
39669377|a|Background: We aimed to assess whether neuron-specific enolase (NSE) and S100-beta levels are associated with early neurological deterioration (END) in patients with acute ischemic stroke (AIS). Methods: We conducted a prospective study between March 2022 and October 2023 in 286 patients with AIS. Serum NSE and S100-beta levels on admission and at 24 and 48 h after stroke onset were measured using electrochemiluminescence immunoassays. Outcomes included END events within 48 h of admission and unfavorable neurological outcomes at 3 months. Results: Patients with END had higher serum NSE and S100-beta levels. Patients with poor prognosis had higher serum NSE and S100-beta levels. Serum NSE (on admission) was an independent biomarker for END in AIS patients and for unfavorable recovery at 3 months. In addition, serum S100-beta was an independent biomarker of unfavorable recovery after 3 months in patients with AIS. Conclusion: Serum NSE on admission and S100-beta at 48 h of stroke onset may serve as biomarkers of short-term clinical outcome in patients with AIS. Elevated serum NSE and S100-beta levels may be useful tools to predict prognosis in patients with AIS.
39669377	19	42	neuron-specific enolase	Gene	2026
39669377	47	56	S100-beta	Gene	6285
39669377	66	92	neurological deterioration	Disease	MESH:D009422
39669377	122	130	patients	Species	9606
39669377	136	151	ischemic stroke	Disease	MESH:D002544
39669377	192	215	neuron-specific enolase	Gene	2026
39669377	217	220	NSE	Gene	2026
39669377	226	235	S100-beta	Gene	6285
39669377	269	295	neurological deterioration	Disease	MESH:D009422
39669377	297	300	END	Disease	MESH:D009461
39669377	305	313	patients	Species	9606
39669377	319	340	acute ischemic stroke	Disease	MESH:D000083242
39669377	342	345	AIS	Disease	MESH:D000083242
39669377	433	441	patients	Species	9606
39669377	447	450	AIS	Disease	MESH:D000083242
39669377	458	461	NSE	Gene	2026
39669377	466	475	S100-beta	Gene	6285
39669377	521	527	stroke	Disease	MESH:D020521
39669377	611	614	END	Disease	MESH:D009461
39669377	707	715	Patients	Species	9606
39669377	721	724	END	Disease	MESH:D009461
39669377	742	745	NSE	Gene	2026
39669377	750	759	S100-beta	Gene	6285
39669377	768	776	Patients	Species	9606
39669377	814	817	NSE	Gene	2026
39669377	822	831	S100-beta	Gene	6285
39669377	846	849	NSE	Gene	2026
39669377	898	901	END	Disease	MESH:D009461
39669377	905	908	AIS	Disease	MESH:D000083242
39669377	909	917	patients	Species	9606
39669377	979	988	S100-beta	Gene	6285
39669377	1060	1068	patients	Species	9606
39669377	1074	1077	AIS	Disease	MESH:D000083242
39669377	1097	1100	NSE	Gene	2026
39669377	1118	1127	S100-beta	Gene	6285
39669377	1139	1145	stroke	Disease	MESH:D020521
39669377	1210	1218	patients	Species	9606
39669377	1224	1227	AIS	Disease	MESH:D000083242
39669377	1244	1247	NSE	Gene	2026
39669377	1252	1261	S100-beta	Gene	6285
39669377	1313	1321	patients	Species	9606
39669377	1327	1330	AIS	Disease	MESH:D000083242
39669377	Positive_Correlation	MESH:D009461	6285
39669377	Positive_Correlation	MESH:D009461	2026
39669377	Association	MESH:D009422	6285
39669377	Association	MESH:D000083242	2026
39669377	Association	MESH:D002544	6285
39669377	Association	MESH:D000083242	6285
39669377	Association	MESH:D009422	2026

